Back to Search Start Over

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)

Authors :
Xian-Tao Zeng
Ying-Hui Jin
Tong-Zu Liu
Fang-Ming Chen
De-Gang Ding
Meng Fu
Xin-Quan Gu
Bang-Min Han
Xing Huang
Zhi Hou
Wan-Li Hu
Xin-Li Kang
Gong-Hui Li
Jian-Xing Li
Pei-Jun Li
Chao-Zhao Liang
Xiu-Heng Liu
Zhi-Yu Liu
Chun-Xiao Liu
Jiu-Min Liu
Guang-Heng Luo
Yi Luo
Wei-Jun Qin
Jian-Hong Qiu
Jian-Xin Qiu
Xue-Jun Shang
Ben-Kang Shi
Fa Sun
Guo-Xiang Tian
Ye Tian
Feng Wang
Yin-Huai Wang
Yu-Jie Wang
Zhi-Ping Wang
Zhong Wang
Qiang Wei
Min-Hui Xiao
Wan-Hai Xu
Fa-Xian Yi
Chao-Yang Zhu
Qian-Yuan Zhuang
Li-Qun Zhou
Xiao-Feng Zou
Nian-Zeng Xing
Da-Lin He
Xing-Huan Wang
the Chinese Urological Doctor Association (CUDA)
Urological Association of Chinese Research Hospital Association (CRHA-UA)
Uro-Health Promotive Association of China International Exchange and Promotive Association for Medical and Health Care (CPAM-UHPA)
Source :
Military Medical Research, Vol 9, Iss 1, Pp 1-19 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2018, we issued the guideline “2018 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 23 carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different populations incorporating the efficacy and safety of TUPKP in the treatment of normal volume (

Details

Language :
English
ISSN :
20549369
Volume :
9
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Military Medical Research
Publication Type :
Academic Journal
Accession number :
edsdoj.06a8c05b012497ca1723331a9da92d7
Document Type :
article
Full Text :
https://doi.org/10.1186/s40779-022-00371-6